Task: Answer the multiple choice question.
Query: Which drug exhibits a 3.193\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCCC4=O)CC3)sc2c1
b: Cc1ccccc1NC(=O)Nc1ccc2c(c1)OCO2
Answer: a. Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCCC4=O)CC3)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCCC4=O)CC3)sc2c1
Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCCC4=O)CC3)sc2c1
1-(4,6-dimethyl-1,3-benzothiazol-2-yl)-N-[3-(2-oxopyrrolidin-1-yl)propyl]piperidine-4-carboxamide